Susquehanna International Group’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.48M Buy
371,463
+41,557
+13% +$389K ﹤0.01% 1677
2025
Q1
$4.05M Buy
329,906
+202,349
+159% +$2.49M ﹤0.01% 1439
2024
Q4
$1.69M Sell
127,557
-41,149
-24% -$544K ﹤0.01% 2209
2024
Q3
$3.25M Buy
168,706
+66,679
+65% +$1.28M ﹤0.01% 1423
2024
Q2
$2.09M Sell
102,027
-634,121
-86% -$13M ﹤0.01% 1735
2024
Q1
$17.5M Buy
736,148
+711,751
+2,917% +$16.9M ﹤0.01% 416
2023
Q4
$527K Sell
24,397
-92,493
-79% -$2M ﹤0.01% 3788
2023
Q3
$1.7M Buy
116,890
+98,220
+526% +$1.43M ﹤0.01% 1993
2023
Q2
$391K Sell
18,670
-90,655
-83% -$1.9M ﹤0.01% 3940
2023
Q1
$2.31M Buy
109,325
+88,637
+428% +$1.87M ﹤0.01% 1802
2022
Q4
$527K Sell
20,688
-35,401
-63% -$901K ﹤0.01% 3145
2022
Q3
$1.35M Buy
+56,089
New +$1.35M ﹤0.01% 2139
2022
Q2
Sell
-115,094
Closed -$2M 6602
2022
Q1
$2M Buy
115,094
+23,566
+26% +$410K ﹤0.01% 2021
2021
Q4
$2M Sell
91,528
-242,278
-73% -$5.3M ﹤0.01% 1971
2021
Q3
$6.38M Buy
333,806
+225,948
+209% +$4.32M ﹤0.01% 1016
2021
Q2
$1.85M Sell
107,858
-46,976
-30% -$807K ﹤0.01% 2162
2021
Q1
$3.46M Buy
154,834
+145,684
+1,592% +$3.26M ﹤0.01% 1544
2020
Q4
$203K Buy
+9,150
New +$203K ﹤0.01% 4257
2020
Q3
Hold
0
4937
2020
Q2
Hold
0
4863
2020
Q1
Sell
-16,129
Closed -$142K 5009
2019
Q4
$142K Sell
16,129
-18,932
-54% -$167K ﹤0.01% 3605
2019
Q3
$262K Buy
+35,061
New +$262K ﹤0.01% 3572
2019
Q2
Hold
0
4987
2019
Q1
Sell
-64,882
Closed -$289K 4379
2018
Q4
$289K Sell
64,882
-33,508
-34% -$149K ﹤0.01% 2613
2018
Q3
$795K Buy
+98,390
New +$795K ﹤0.01% 1649
2018
Q2
Hold
0
4607
2018
Q1
Hold
0
4415